- Home
- GRFS vs INDV Comparison
GRFS vs INDV Comparison
Compare GRFS & INDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GRFS | INDV |
|---|---|---|
| Founded | 1940 | N/A |
| Country | Spain | United States |
| Employees | 25247 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4B | 4.4B |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | GRFS | INDV |
|---|---|---|
| Price | $7.64 | $38.48 |
| Analyst Decision | Hold | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $10.15 | N/A |
| AVG Volume (30 Days) | 569.0K | ★ 1.6M |
| Earning Date | 07-28-2022 | 06-08-2026 |
| Dividend Yield | ★ 1.80% | N/A |
| EPS Growth | N/A | ★ 8100.00 |
| EPS | N/A | ★ 0.69 |
| Revenue | N/A | ★ $1,239,000,000.00 |
| Revenue This Year | $4.49 | N/A |
| Revenue Next Year | $6.42 | N/A |
| P/E Ratio | ★ $18.67 | $55.26 |
| Revenue Growth | N/A | ★ 4.29 |
| 52 Week Low | $7.26 | $13.45 |
| 52 Week High | $11.14 | $41.00 |
Technical Indicators
Market Signals| Indicator | GRFS | INDV |
|---|---|---|
| Relative Strength Index (RSI) | 47.21 | 59.21 |
| Support Level | $7.64 | $35.36 |
| Resistance Level | $8.24 | $41.00 |
| Average True Range (ATR) | 0.18 | 1.35 |
| MACD | -0.01 | 0.09 |
| Stochastic Oscillator | 44.02 | 91.51 |
Price Performance
Historical ComparisonAbout GRFS Grifols S.A.
Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.
About INDV Indivior PLC
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).